200 related articles for article (PubMed ID: 7131445)
21. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures.
Cagnacci A; Zanin R; Cannoletta M; Generali M; Caretto S; Volpe A
Fertil Steril; 2007 Dec; 88(6):1603-8. PubMed ID: 17481628
[TBL] [Abstract][Full Text] [Related]
22. [Gestagen treatment of endometrial carcinoma--theoretical and practical application].
Sugawa T; Sako H
Gan To Kagaku Ryoho; 1984 May; 11(5):1005-11. PubMed ID: 6721511
[TBL] [Abstract][Full Text] [Related]
23. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
24. [Genesis of uterine hemorrhages during menopause].
Griaznova IM; Poraĭ-Koshits KV; Isaeva EG
Akush Ginekol (Mosk); 1974 Feb; (2):48-52. PubMed ID: 4447177
[No Abstract] [Full Text] [Related]
25. Current status of estrogen therapy for the menopause.
Hammond CB; Maxson WS
Fertil Steril; 1982 Jan; 37(1):5-25. PubMed ID: 6277697
[No Abstract] [Full Text] [Related]
26. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
27. Endometrial carcinoma: an aberration of endometrial cell differentiation.
Satyaswaroop PG; Mortel R
Am J Obstet Gynecol; 1981 Jul; 140(6):620-3. PubMed ID: 7258233
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
[TBL] [Abstract][Full Text] [Related]
29. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
de Lignieres B
J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
[TBL] [Abstract][Full Text] [Related]
30. Endometrial cancer. A review.
Pagel J; Bock JE
Dan Med Bull; 1984 Aug; 31(4):333-45. PubMed ID: 6383739
[No Abstract] [Full Text] [Related]
31. Progestins in the menopause in healthy women and breast cancer patients.
Pasqualini JR
Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024
[TBL] [Abstract][Full Text] [Related]
32. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
33. [Estrogens and progestins in hormone replacement therapy in menopause].
La Vecchia C
Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
[TBL] [Abstract][Full Text] [Related]
34. Estrogen replacement therapy and endometrial hyperplasia.
Tsang P
JAMA; 1996 Jun; 275(24):1880-1. PubMed ID: 8648861
[No Abstract] [Full Text] [Related]
35. [Anomalous uterine bleeding in the perimenopause: fibromatosis, hyperplastic endometriopathy and GnRH analogs].
Vitale G; Linciano M; Salamanca S; Ferrari P
Minerva Ginecol; 1994 Jun; 46(6):317-20. PubMed ID: 7936383
[TBL] [Abstract][Full Text] [Related]
36. Current status of endocrine therapy for advanced breast cancer.
Bland KI
Ann Surg Oncol; 1999 Dec; 6(8 Suppl):4S-7S. PubMed ID: 10619452
[No Abstract] [Full Text] [Related]
37. Endolymphatic stromal myosis: a case with positive estrogen and progesterone receptors and good response to progestins.
Tsukamoto N; Kamura T; Matsukuma K; Imachi M; Uchino H; Saito T; Ono M
Gynecol Oncol; 1985 Jan; 20(1):120-8. PubMed ID: 3965374
[TBL] [Abstract][Full Text] [Related]
38. [Advances and risks in estrogen therapy in the perimenopause].
Lauritzen C
Wien Klin Wochenschr; 1983 Oct; 95(20):748-51. PubMed ID: 6659519
[TBL] [Abstract][Full Text] [Related]
39. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
[TBL] [Abstract][Full Text] [Related]
40. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
